Dr Reddys Laboratories (RDY) Debt Ratio (2012 - 2026)

Dr Reddys Laboratories (RDY) recorded quarterly Debt Ratio of 0.03 in Q1 2026, up 46.37% quarter-over-quarter from 0.02 in Q3 2025, and down 66.25% on a YoY basis from 0.09 in Q1 2025.

Dr Reddys Laboratories (RDY) Debt Ratio (2012 - 2026) Analysis & Trends

Dr Reddys Laboratories' Debt Ratio history runs 14 years deep, the most recent figure standing at 0.03 for Q1 2026.

  • In Q1 2026, Debt Ratio fell 66.25% year-over-year to 0.03; the TTM figure through Mar 2026 stood at 0.03 (down 66.25% YoY), while the FY2026 annual figure was 0.03, up 69.01% from the prior year.
  • Debt Ratio was 0.03 for Q1 2026 at Dr Reddys Laboratories, up from 0.02 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.09 in Q1 2025 to a low of 0.01 in Q3 2022.
  • Historically, Debt Ratio has averaged 0.04 across 5 years, with a median of 0.02 in 2022.
  • The sharpest annual moves came in 2022 and 2023: Debt Ratio tumbled 94.18% in 2022, then jumped 959.2% in 2023.
  • A 5-year view of Debt Ratio shows it stood at 0.01 in 2022, then surged by 959.2% to 0.07 in 2023, then tumbled by 75.82% to 0.02 in 2024, then soared by 35.91% to 0.02 in 2025, then jumped by 46.37% to 0.03 in 2026.
  • The last three Debt Ratio figures came in at 0.03 (Q1 2026), 0.02 (Q3 2025), and 0.09 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 0.42
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 0.60
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.01
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.30
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 0.35
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 0.24
10 Dr Reddys Laboratories 122.03 Mn -51.98 Mn 368.55 Mn 0.03

Historic Data

Download Data
DateValue
Mar 31, 2026 0.03
Sep 30, 2025 0.02
Mar 31, 2025 0.09
Sep 30, 2024 0.02
Mar 31, 2024 0.05
Sep 30, 2023 0.07
Mar 31, 2023 0.02
Sep 30, 2022 0.01
Mar 31, 2022 0.02
Sep 30, 2021 0.11
Mar 31, 2021 0.03
Sep 30, 2020 0.13
Mar 31, 2020 0.08
Sep 30, 2019 0.07
Mar 31, 2019 0.15
Sep 30, 2018 0.20
Mar 31, 2018 0.11
Sep 30, 2017 0.20
Mar 31, 2017 0.03
Sep 30, 2016 0.08